Through correlation analysis with clinical parameters such as HRCT, lung function, and blood gas analysis, we conclude that the expression levels of serum VEGF and KL-6 can be used as important indicators for assessing the severity of IPF-ILD, monitoring disease progression and predicting prognosis. This evidence concerns the gene MUC1 and idiopathic pulmonary fibrosis.